Engineering blood exosomes for tumor-targeting efficient gene/chemo combination therapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Therapy

Background:

• Developing effective nanoplatforms for combination therapy is crucial for enhancing treatment efficacy.
• Exosomes are promising natural nanocarriers due to their inherent ability to carry multiple therapeutic agents.
• Engineering exosomes for tumor-targeted gene and chemotherapy requires optimization of safety, yield, and functionality.

Purpose of the Study:

• To engineer blood exosomes as a versatile combinatorial delivery system for tumor-targeted gene/chemo combination therapy.
• To co-load doxorubicin (Dox) and miRNA21 inhibitor (miR-21i) into engineered exosomes.
• To enhance tumor targeting and intracellular delivery through exosome membrane modification.

Main Methods:

• Blood exosomes were engineered by co-embedding doxorubicin (Dox) and cholesterol-modified miRNA21 inhibitor (miR-21i) into their lipid bilayer.
• Magnetic molecules and endosomolytic peptide L17E were attached to the exosome membrane via ligand-receptor coupling and electrostatic interactions.
• The engineered exosomes were evaluated for their loading capacity, tumor targeting, endosome escape, and therapeutic efficacy in vivo.

Main Results:

• Engineered exosomes successfully co-loaded Dox and miR-21i with high payloads, preserving intrinsic exosome features.
• The modified exosomes demonstrated enhanced tumor accumulation and improved endosome escape due to integrated magnetic molecules and L17E peptides.
• Significant tumor growth inhibition was observed in tumor-bearing mice with no noticeable side effects, confirming effective combination therapy.

Conclusions:

• Engineered blood exosomes serve as a feasible co-delivery nanosystem for efficient, tumor-targeted combination therapy.
• This approach demonstrates the potential for developing a general platform for safe and effective combination cancer treatments.
• Further modifications with different drug combinations could expand the application of this engineered exosome system.